Search
forResearch 10 of 1000+
- 5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
- Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
- Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
- In vitro expansion of human mesenchymal stem cells and hepatocytes using purified platelet derived growth factors, a potential therapeutic modality for liver fibrosis
- Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
- Resident macrophages of the lung and liver: The guardians of our tissues
- Integrin β1 Establishes Liver Microstructure and Modulates Transforming Growth Factor β during Liver Development and Regeneration
- Clinical and Trichoscopic Graded Live Visual Scale for Androgenetic Alopecia
Community 10 of 86
- Deciding Between Oral or Topical Min and Fin with Fatty Liver
- Increased liver enzymes from hairloss medications.
- Can liver problems be associated with response to the oral minoxidil?
- Sensitive liver, topical fin safe to try?
- Attention Finasteride / Dutasteride and Your liver
- liver problem from finasteride/dutasteride
- 28M: Can I Combine Oral and Topical Finasteride with Elevated Liver Enzymes?
- Could fatty liver(other issues related to it..)play a role in Dupa/Aga?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Finally live! alcohol-free, propylene glycol–free topical finasteride foam
Learn
— no results
Try a deeper search in learn →